Results 31 to 40 of about 10,275,652 (198)

Stage II Seminoma: Why Chemotherapy Should Remain a Standard

open access: yesEuropean Urology Open Science, 2023
Chemotherapy (three cycles of bleomycin + etoposide + cisplatin or four of etoposide + cisplatin) cures the vast majority of stage II seminomas. Retroperitoneal lymph node dissection (RPLND) is safe in early-stage seminoma, but the risk of relapse is not
Natacha Naoun   +2 more
doaj   +1 more source

Stage II: Ranking of lectures.

open access: yes, 2019
Stage II: Ranking of lectures.
Mary E. Wood (4248898)   +5 more
core   +1 more source

Risk factors for postoperative recurrence in patients with stage II colorectal cancer

open access: yesBMC Cancer, 2023
Background Recurrences are the main reasons for unfavorable outcomes for patients with stage II colorectal cancer (CRC). To obtain a clear understanding of the high-risk factors, further investigation is warranted.
Zhi-Zhong Xiong   +7 more
doaj   +1 more source

Musicie być mocni! : drogowskazy Jana Pawła II dla niepełnosprawnych [PDF]

open access: yes, 2008
Biblioteka Instytutu Jana Pawła II w Wałbrzychu ;
Jan Paweł II (papież ; 1920-2005)
core  

Centrality analysis of stage-II network.

open access: yes, 2016
Centrality analysis of stage-II network.
Ashok Palaniappan (3165975)   +2 more
core   +1 more source

Moduland decomposition of stage-II network.

open access: yes, 2016
Moduland decomposition of stage-II network.
Ashok Palaniappan (3165975)   +2 more
core   +1 more source

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer

open access: yesJournal of Hematology & Oncology, 2011
Background Although evaluation of at least 12 lymph nodes (LNs) is recommended as the minimum number of nodes required for accurate staging of colon cancer patients, there is disagreement on what constitutes an adequate identification of such LNs ...
Bumpers Harvey L   +10 more
doaj   +1 more source

Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review

open access: yesMedicina, 2022
Objective: to show an overview on the treatments’ options for stage I and II oropharyngeal carcinomasquamous cell carcinoma (OPSCC). Background: The traditional primary treatment modality of OPSCC at early stages is intensity modulated radiation therapy (
Giuseppe Meccariello   +6 more
doaj   +1 more source

GO enrichment analysis of Stage-II network.

open access: yes, 2016
GO enrichment analysis of Stage-II network.
Ashok Palaniappan (3165975)   +2 more
core   +1 more source

Mutational load comparison between stage II patients groups.

open access: yes, 2020
Mutational load comparison between stage II patients groups.
Javier Rasero (4591531)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy